Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00260728 · ClinicalTrials.gov registry record · Phase 2
The Boston Scientific ACCESS Trial
A Phase 2 study, sponsored by Maquet Cardiovascular.
- Terminated
- Registry status
- Phase 2
- Development phase
- 149
- Enrollment target
NCT00260728: Clinical Trial Phase 2 study, sponsored by Maquet Cardiovascular.
NCT00260728 is a Phase 2 study that was terminated before completion, run by Maquet Cardiovascular. The registered enrollment target is 149 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (12% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00260728, a Phase 2 study, was terminated before completion, sponsored by Maquet Cardiovascular.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 149 participants
- Enrollment target
Study Summary
The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialysis.
Interventions
- DEVICE vascular access graft implantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2005-12 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Why NCT00260728 stopped before completion
NCT00260728 is an interventional study that assigns participants to a tested intervention. The registered 149 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (12% higher).
The record links to 0 conditions, and to 1 intervention - of which vascular access graft implantation is the first listed.
NCT00260728 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00260728 about?
NCT00260728 is a clinical study titled "The Boston Scientific ACCESS Trial". The Boston Scientific ACCESS trial seeks to study the safety and to evaluate the success of the Fusion™ Vascular Access Graft for patients in need of early vascular access for hemodialysis.
What is the current status of trial NCT00260728?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 149 participants. The study started on 2005-12. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00260728?
The interventions under investigation include: vascular access graft implantation (DEVICE).
Who is sponsoring clinical trial NCT00260728?
This trial is sponsored by Maquet Cardiovascular, which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00260728's enrollment target sits among peer trials
149 491st of 2000 higher than 1,510 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04188535 · 149 participants · NA
Serial MRI Scans During Radiation Therapy
- NCT05828511 · 149 participants · Phase 1
A Window of Opportunity Trial to Learn if Linvoseltamab is Safe and Well Tolerated, and How Well it Works in Adult Participants With Recently Diagnosed Multiple Myeloma Who Have Not Already Received Treatment
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia